Mary Caffrey

Part 1: See Part 2 in the September issue of Evidence-Based Diabetes Management.

Training seniors to manage their own diabetes takes many hands--most notably, those of the patients themselves. A look at how a diabetes management program serving a diverse population approaches this task.

The collaboration is the latest in a series of partnerships for diabetes care announced by the medical device maker.

Data sharing in precision medicine has not been without controversy. Some genetic testing companies say security on public databases is less than stellar, giving them a reason to decline sharing their information warehouses.

The practical document will be of greatest use to smaller hospitals still building antibiotic stewardship programs from scratch. CDC estimates that drug-resistant bacteria infect 2 million people a year and cause 23,000 deaths.

The largest group of endocrinologists first declared obesity a disease in 2012. Guidelines call for making relief of weight-related complications the first priority, not weight loss per se.

The smallest overall increase in the MMI in 15 years is masked by the fact that employees are bearing an increasingly large share of healthcare costs.

A recent study showed patients with type 2 diabetes did better if given the combination therapy at the outset than if given 1 of the components as monotherapy.

Finding diabetes and treating it early can prevent high healthcare costs in the long term, the authors day.

The updated label reflects research that shows how hard it is to consume key nutrients and maintain calorie limits in a diet overwhelmed by sugar. The label will be a legacy of First Lady Michelle Obama's focus on better nutrition to combat childhood obesity.

US and European professional societies coordinated their announcement to reduce confusion for physicians and payers.

The sequence of events that led to Thursday's complaint points to a coordinated effort to challenge Myriad Genetics' long-held position that it does not share information on public databases.

Right now, islet transplant therapy requires donated cells. The hope is that lab-grown islets could vastly expand the pool of patients who could get treatment.

The online system allows providers in the field to match unidentified microbes with CDC's pathogen library in a matter of hours. In the past, it could take up to a week to make a positive identification.

Governor Mary Fallin's proposal to embrace Medicaid expansion and fund the state share with a cigarette tax comes nearly a year after HHS Secretary Sylvia Burwell made an explicit appeal to work with governors in conservative states.

The findings are consistent with other results that have shown sizable drops in A1C, as well as the ability to control blood pressure in patients who previously failed to meet targets.

The report highlights insights from experts at the recent meeting, Patient-Centered Diabetes Care. Failing to treat obesity will only cost more later, experts said.

Officials are using innovative methods like automatically enrolling beneficiaries based on their eligibility for foods stamps, and adding a large group that takes part in an existing New Orleans-area health project but currently lacks prescription drug coverage.

As CDC reports a record number of deaths from hepatitis C, it seeks to raise awareness of the need for screening and treatment. Authors and the editor of a special issue of The American Journal of Managed Care will take part in a briefing on the issue.

While final decisions will come in Septembers, Aetna's early word comes in contrast with that of other large insurers heading into 2017.

Five states report that 1 in 3 adults meet the CDC definition of obesity, which is having a body mass index of 30 or more.

While health plans and PBMs have taken a variety of approaches to control spending on the new class of cholesterol fighting drugs, Cigna is the first to reach value-based agreements with the drug makers.

Exclusivity deals in managed care to hold down the cost of drug therapy are not new. But requiring persons with type 1 diabetes to use insulin pumps from a single manufacturer has brought out a whole different reaction.

Experiments with mice suggest a potential early treatment to avoid a deadly infection.

FDA's requirement for large, cardiovascular safety trials for all new diabetes and obesity drugs has created a "cottage industry" that some see as necessary but others feel drives up drug costs.

The matchstick-like device is placed under the skin and continuously delivers exenatide to ovecome a chief hurdle in diabetes care: poor adherence.

Six years after the adoption of the Affordable Care Act, a physicians' group says corporate interests are pushing aside the concerns of doctors and the needs of patients.

Even though prices for both drugs in Britain was less than half the list price in the United States, NICE demanded further discounts before issuing a draft guidance that the therapies were appropriate for those who cannot otherwise lower cholesterol.

Smoking rates reported by insurers serving the ACA exchanges were consistently lower than findings from the CDC, suggesting that some are not being honest to avoid surcharges.

Discovery of the mechanism that connects low testosterone with diabetes could lead to better treatments for men as they age.